Repaglinide + Montelukast Interaction
Moderateinteraction on record
Description
CYP2C8 inhibitor. Repaglinide dose reductions and increased glucose monitoring may be required.
Mechanism
CYP2C8 inhibition
Source: NLP:repaglinide
CYP2C8 inhibitor. Repaglinide dose reductions and increased glucose monitoring may be required.
CYP2C8 inhibition
Source: NLP:repaglinide